3717434|t|Hypertension associated with oral administration of physostigmine in a patient with Alzheimer's disease.
3717434|a|The hemodynamic effects of physostigmine, a cholinomimetic drug used in the experimental treatment of Alzheimer's disease, are largely unknown. The author describes the development of episodes of hypertension in an elderly patient with Alzheimer's disease following treatment with oral physostigmine.
3717434	0	12	Hypertension	Disease	MESH:D006973
3717434	52	65	physostigmine	Chemical	MESH:D010830
3717434	71	78	patient	Species	9606
3717434	84	103	Alzheimer's disease	Disease	MESH:D000544
3717434	132	145	physostigmine	Chemical	MESH:D010830
3717434	207	226	Alzheimer's disease	Disease	MESH:D000544
3717434	301	313	hypertension	Disease	MESH:D006973
3717434	328	335	patient	Species	9606
3717434	341	360	Alzheimer's disease	Disease	MESH:D000544
3717434	391	404	physostigmine	Chemical	MESH:D010830
3717434	Positive_Correlation	MESH:D010830	MESH:D006973
3717434	Negative_Correlation	MESH:D010830	MESH:D000544

